Folliculitis Clinical Trial
— acneOfficial title:
Isolation and Comparative Efficacy of the Combination of beclometasona0, 025% + Gentamicin 0.1% + Clotrimazole 1% Topical Dermatological Cream of GLENMARK PHARMACEUTICALS, in Patients Infected With Acne
Verified date | November 2022 |
Source | Azidus Brasil |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this trial is to evaluate the comparative efficacy of the combination of Clotrimazole + Gentamicin + Beclomethasone in study subjects with a condition of contaminated dermatosis showing bilateral symmetrical lesions.
Status | Suspended |
Enrollment | 80 |
Est. completion date | September 2007 |
Est. primary completion date | August 2007 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - Subject search of both sexes, regardless of color or social class - From age to 18, with good mental health - Carriers of two outbreaks of acne contaminated - Subjects who agree to return follow-up visits - Research subjects who agree to participate and sign the Deed of Consent Exclusion Criteria: - Subject Research carriers of susceptibility to gentamicin - Research subjects suffering from sensitivity to clotrimazole - Research subjects suffering from sensitivity to beclomethasone - Research subjects who are making use of steroids or steroidal anti-inflammatory and non-steroidal drugs or who made use of topical or oral 15 days ago - Research subjects who are doing immunosuppressive treatment - Research subjects with a diagnosis of eosinophilic folliculitis or Pseudo-folliculitis barbae and groin - Pregnant and lactating |
Country | Name | City | State |
---|---|---|---|
Brazil | LAL Clinica | Valinhos | SP |
Lead Sponsor | Collaborator |
---|---|
Azidus Brasil |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Efficacy of the treatment in patient with infected dermatoses | 21 days of treatment | ||
Secondary | evaluate the safety and tolerability of both formulations in the course of treatmen | 21 days of treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00746109 -
Study of Wound Packing After Superficial Skin Abscess Drainage
|
Phase 4 | |
Completed |
NCT00352612 -
Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
|
Phase 4 | |
Completed |
NCT05345093 -
Evaluation of Safety and Performance of Ialuxid Gel in Treatment of Acne Vulgaris, and Folliculitis
|
N/A | |
Completed |
NCT01094444 -
Investigation of the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis
|
Phase 2 | |
Completed |
NCT06052241 -
Artificial Intelligence-based Prescription of Personalized Scalp Cosmetics
|
N/A | |
Completed |
NCT00289588 -
An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers
|
N/A | |
Completed |
NCT05793164 -
Characterization and Risk Factors of Folliculitis After Hair Transplantation
|
||
Completed |
NCT01126268 -
Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection
|
Phase 4 |